The solute carrier family 2 member 4 (SLC2A4) gene, encoding for the insulin-dependent glucose transporter type 4 (GLUT4) in muscle and adipose tissue, has therapeutic potential for the treatment of insulin resistance in obesity and in specific cancer types [3,4]. The gene discussed is SLC2A4; the disease is Insulin resistance.